NCT06974890 Effects of Shuttle Balance Training on Balance , Gait and Postural Control in Children With Mild Cognitive Impairment
| NCT ID | NCT06974890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-04-15 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the impact of Shuttle Balance Training (SBT) on balance, gait, and postural control among children diagnosed with mild cognitive impairment (MCI). Mild cognitive impairment in children often manifests as challenges in cognitive processing, motor coordination, and daily activities that involve balance and movement. The research will employ a randomized controlled trial (RCT) design, involving children aged 6-12 years diagnosed with MCI. Participants will be randomly assigned to either an experimental group receiving Shuttle Balance Training or a control group receiving standard care or placebo interventions. The Shuttle Balance Training protocol consists of structured sessions focusing on dynamic balance exercises, coordination drills, and proprioceptive challenges using shuttle devices. Training sessions will be conducted thrice weekly over a period of 12 weeks, with each session lasting approximately 45 minutes. The study will be randomized controlled trial. Total \_\_ subjects will be assigned by non probability convenient sampling technique. They were randomly assigned to experimental and control groups. The Berg balance scale, limits of stability test, GOAL test, Timed up and go tools will be used. Tests will be used as outcome measure tools for balance, walk, coordination and Physical activity. All measures will be taken at baseline and at the end of treatment session. The collected data will be analyzed in Statistical Package for the Social Sciences (SPSS) 25.0 version. If data will be normally distributed then parametric if not normally distributed than non-parametric test will be apply.
Eligibility Criteria
Inclusion Criteria: Children with mild cognitive impairment (50-70%IQ) * Age group from 6 to 12 years * Both male and female * Children must have the physical and cognitive ability to engage in the activities * Children should be in generally good health, without severe medical conditions or orthopedic issues Exclusion Criteria: * Children with severe cognitive impairment * Children who have severe neurological disorders * Children with visual and auditory impairment * Children with severe sensory processing disorders
Contact & Investigator
ZAHRA AHMAD, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06974890 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06974890 currently recruiting?
Yes, NCT06974890 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06974890 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06974890 clinical trial?
NCT06974890 is sponsored by Riphah International University. The principal investigator is ZAHRA AHMAD, MS-PPT at Riphah International University. The trial plans to enroll 24 participants.